These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 20156489

  • 1. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA, Carnevale UA, Treno C, Sadile AG, Melisi D, Arra C, Ibba M, Schirru C, Carboni E.
    Behav Brain Res; 2010 Jun 26; 210(1):99-106. PubMed ID: 20156489
    [Abstract] [Full Text] [Related]

  • 2. Excitatory amino acids in the forebrain of the Naples high-excitability rats: neurochemical and behavioural effects of subchronic D-aspartate and its diethyl ester prodrug.
    Ruocco LA, Di Pizzo A, Carnevale UA, Murolo M, Sadile AG, Arra C, Topo E, D'Aniello A, Curcio A, Melisi D, Rimoli MG.
    Behav Brain Res; 2009 Mar 02; 198(1):37-44. PubMed ID: 19041899
    [Abstract] [Full Text] [Related]

  • 3. Differential prepuberal handling modifies behaviour and excitatory amino acids in the forebrain of the Naples High-Excitability rats.
    Ruocco LA, Gironi Carnevale UA, Sica A, Arra C, Topo E, Di Giovanni M, D'Aniello A, Sadile AG.
    Behav Brain Res; 2009 Mar 02; 198(1):29-36. PubMed ID: 18950660
    [Abstract] [Full Text] [Related]

  • 4. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T.
    J Neurochem; 2010 Jul 02; 114(1):259-70. PubMed ID: 20403082
    [Abstract] [Full Text] [Related]

  • 5. Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine.
    Tzavara ET, Bymaster FP, Overshiner CD, Davis RJ, Perry KW, Wolff M, McKinzie DL, Witkin JM, Nomikos GG.
    Mol Psychiatry; 2006 Feb 02; 11(2):187-95. PubMed ID: 16231039
    [Abstract] [Full Text] [Related]

  • 6. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.
    Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):34-41. PubMed ID: 17714843
    [Abstract] [Full Text] [Related]

  • 7. Intranasal application of dopamine reduces activity and improves attention in Naples High Excitability rats that feature the mesocortical variant of ADHD.
    Ruocco LA, de Souza Silva MA, Topic B, Mattern C, Huston JP, Sadile AG.
    Eur Neuropsychopharmacol; 2009 Oct 01; 19(10):693-701. PubMed ID: 19328660
    [Abstract] [Full Text] [Related]

  • 8. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.
    Swanson CJ, Perry KW, Koch-Krueger S, Katner J, Svensson KA, Bymaster FP.
    Neuropharmacology; 2006 May 01; 50(6):755-60. PubMed ID: 16427661
    [Abstract] [Full Text] [Related]

  • 9. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.
    Ruocco LA, Treno C, Gironi Carnevale UA, Arra C, Mattern C, Huston JP, de Souza Silva MA, Nikolaus S, Scorziello A, Nieddu M, Boatto G, Illiano P, Pagano C, Tino A, Sadile AG.
    Amino Acids; 2014 Sep 01; 46(9):2105-22. PubMed ID: 24862315
    [Abstract] [Full Text] [Related]

  • 10. Elevated forebrain excitatory L-glutamate, L-aspartate and D-aspartate in the Naples high-excitability rats.
    Ruocco LA, Gironi Carnevale UA, Sadile AG, Sica A, Arra C, Di Maio A, Topo E, D'Aniello A.
    Behav Brain Res; 2009 Mar 02; 198(1):24-8. PubMed ID: 19073221
    [Abstract] [Full Text] [Related]

  • 11. Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
    Liu LL, Yang J, Lei GF, Wang GJ, Wang YW, Sun RP.
    Basic Clin Pharmacol Toxicol; 2008 Jun 02; 102(6):527-32. PubMed ID: 18346050
    [Abstract] [Full Text] [Related]

  • 12. Effects of atomoxetine, desipramine, d-amphetamine and methylphenidate on impulsivity in juvenile rats, measured in a T-maze procedure.
    Bizot JC, David S, Trovero F.
    Neurosci Lett; 2011 Feb 01; 489(1):20-4. PubMed ID: 21129437
    [Abstract] [Full Text] [Related]

  • 13. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
    Sasané R, Hodgkins P, Meijer W.
    Curr Med Res Opin; 2010 Nov 01; 26(11):2565-74. PubMed ID: 20863165
    [Abstract] [Full Text] [Related]

  • 14. Immunization with DISC1 protein in an animal model of ADHD influences behavior and excitatory amino acids in prefrontal cortex and striatum.
    Ruocco LA, Treno C, Gironi Carnevale UA, Arra C, Boatto G, Pagano C, Tino A, Nieddu M, Michel M, Prikulis I, Carboni E, de Souza Silva MA, Huston JP, Sadile AG, Korth C.
    Amino Acids; 2015 Mar 01; 47(3):637-50. PubMed ID: 25595600
    [Abstract] [Full Text] [Related]

  • 15. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.
    Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW.
    Neuropsychopharmacology; 2002 Nov 01; 27(5):699-711. PubMed ID: 12431845
    [Abstract] [Full Text] [Related]

  • 16. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun 01; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 17. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder].
    Castellanos FX, Acosta MT.
    Rev Neurol; 2011 Mar 01; 52 Suppl 1():S155-60. PubMed ID: 21365598
    [Abstract] [Full Text] [Related]

  • 18. Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex.
    Horner WE, Johnson DE, Schmidt AW, Rollema H.
    Eur J Pharmacol; 2007 Mar 08; 558(1-3):96-7. PubMed ID: 17198700
    [Abstract] [Full Text] [Related]

  • 19. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
    Newcorn JH, Kratochvil CJ, Allen AJ, Casat CD, Ruff DD, Moore RJ, Michelson D, Atomoxetine/Methylphenidate Comparative Study Group.
    Am J Psychiatry; 2008 Jun 08; 165(6):721-30. PubMed ID: 18281409
    [Abstract] [Full Text] [Related]

  • 20. Different adaptations in ventral tegmental area dopamine neurons in control and ethanol exposed rats after methylphenidate treatment.
    Shen RY, Choong KC.
    Biol Psychiatry; 2006 Apr 01; 59(7):635-42. PubMed ID: 16199009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.